status: Recognised & Endorsed

Chair (s): Sergio Bonini, Dawei Lin, Andrea Jackson Dipina, Anne Cambon-Thomsen

Group Email: [group_email]

Secretariat Liaison: [field_secretariat_liaison]


 

This is the subgroup of the RDA-COVID-19 working group focusing on Clinical.

 

Clinical subgroup priorities:

  1. A set of guideline documents, highlighting the primary data [and software/code] sharing resources in Clinical research, addressing different data types and cross-cutting themes.

  2. Resource [data and software/code] List(s) in Clinical research.

  3. A Decision Tree tool to facilitate navigation to specific Clinical Resources.

 

To provide feedback on the "RDA COVID-19 Guidelines and Recommendations":

The current draft of the "RDA COVID-19 Guidelines and Recommendations" can be found in the Outputs section of the main COVID-19 WG webpage; be sure to select the most current version that is attached for review, and provide comments using the "Add new comment" link below the attachments.

 

Posts

28
October
2022

Invitation to participate in 'A Decade of Data: 10 Years of the RDA' events and activities

by Connie Clare

Good day, The RDA Secretariat would like to invite the RDA Covid-19 groups to participate in ‘A Decade of Data’: Celebrating 10 Years of the Research Data Alliance’. 10 months to celebrate 10 years of the RDA
0 | Add new comment
07
May
2021

Workshop 7 June: Leveraging the COVID-19 response towards advancing data interoperability

by Hilary Hanahoe

Dear RDA COVID-19 Working group members The European Commission (EC) and the Portuguese presidency are organising a workshop “Riding the Next Wave of Research Data: Leveraging the COVID-19 response towards advancing data interoperability” which will be held in Lisbon, on 7th June 2021 10h30-16h30 CEST, at the National Laboratory of Civil Engineering (LNEC), Avenida do Brasil, 101, 1700-066 Lisbon. This will be a hybrid event with the possibility of participation in person or by videoconference.
0 | Add new comment
07
May
2021

Workshop 7 June: Leveraging the COVID-19 response towards advancing data interoperability

by Hilary Hanahoe

Dear COVID-19 Working Group Members, The European Commission and the Portuguese presidency are organising a workshop with the title: “Riding the Next Wave of Research Data: Leveraging the COVID-19 response towards advancing data interoperability”.
0 | Add new comment
07
May
2021

Riding the Next Wave of Research Data: Leveraging the COVID-19 response towards advancing data interoperability

by Hilary Hanahoe

Dear COVID-19 Working Group Members, The European Commission and the Portuguese presidency are organising a workshop with the title: “Riding the Next Wave of Research Data: Leveraging the COVID-19 response towards advancing data interoperability”.
0 | Add new comment
18
April
2021

Partitioning Pattern of Natural Products Based on Molecular Properties Descriptors Representing Drug-Likeness

by Miroslava Nedyalkova

A cheminformatics procedure for a partitioning model based on 135 natural compounds including Flavonoids, Saponins, Alkaloids, Terpenes and Triterpenes with drug-like features based on a descriptors pool was developed. The knowledge about the applicability of natural products as a unique source for the development of new candidates towards deadly infectious disease is a contemporary challenge for drug discovery. We propose a partitioning scheme for unveiling drug-likeness candidates with properties that are important for a prompt and efficient drug discovery process.
0 | Add new comment
10
March
2021

Open Position Scientific Data Specialist ClinEpiDB resource

by Natalie Meyers

Hello, We have a Scientific Data Specialist job opening that may be of interest to members of RDA COVID-19 Epi & Clinical WG members and will appreciate it if you help us share the opportunity with those who might be interested candidates. 
0 | Add new comment
29
January
2021

RDA VP17 Session proposal submission

by Alexandra Delipalta

Dear RDA-COVID19, RDA COVID-19 Epidemiology, RDA-COVID19-Clinical, RDA-COVID19-Social-Sciences, RDA-COVID19-Community-participation and RDA-COVID19-Legal-Ethical members,    Thank you for your session proposal for Virtual Plenary 17 titled 'Community participation and the RDA COVID-19 Recommendations and Guidelines'. A review of all submitted proposals is now underway by the RDA Technical Advisory Board, with notifications of acceptance planned to be sent by 26 February.   
0 | Add new comment
02
November
2020

FW: [rda-covid19] Final Reminder: Share your Experiences Participating in the RDA COVID-19 WG (new deadline 2 November)

by Anupama Gururaj

Hello Folks, Today is the last day (closing 11/2 at midnight UTC) to add your voice to the working group survey. I hope you will take 10 minutes to do this if you haven't yet! Thanks, Anu Anupama Gururaj Program Officer, DAIT, NIAID, NIH 5601 Fishers Ln., Room 7A76 +1-240-472-2798 (m); +1-301-760-6608 (o) NIAID, NIH, HHS​
0 | Add new comment
22
October
2020

ACTION REQUESTED: Share your Experiences Participating in the RDA COVID-19 WG (deadline 23 October)

by Anupama Gururaj

Hello Folks, Hope you are all healthy and safe. We would like to gently remind you about the survey gathering your feedback, by Friday’s deadline. Thank you to those who already have filled this out, and we look forward to learning from your experiences.
0 | Add new comment
16
June
2020

Last Clinical Subgroup call on use cases and future steps

by Dawei Lin

Dear all, We will have our last call for the subgroup, but it does not mean our work stops. We will discuss a few ideas to follow up on our recommendations and guidelines. 1. What are the use cases for our recommendations and guidelines 2. What do we want to leverage our writing so far? To develop it into a white paper or a publication?
2 | Add new comment

Pages